Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer|Estrogen-receptor-positive Breast Cancer
Interventions: PROCEDURE: Prospective data and sample collection|DRUG: Ketorolac 10 Mg Oral Tablet|DRUG: Pregabalin 75mg
Sponsor: Jules Bordet Institute
Collaborators: KU Leuven|University of Milan